Intestinal lymphangiectasia in systemic lupus erythematosus

Area of Science:

• Gastroenterology
• Rheumatology
• Internal Medicine

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
• Protein-losing enteropathy (PLE) is a rare complication characterized by excessive loss of plasma proteins into the gastrointestinal tract.
• Intestinal lymphangiectasia, a dilation of lymphatic vessels in the small intestine, can lead to PLE.

Observation:

• This report details a case of a female patient diagnosed with SLE.
• The patient presented with protein-losing enteropathy secondary to intestinal lymphangiectasia.
• Clinical symptoms, laboratory results, and intestinal histology were assessed.

Findings:

• Corticosteroid therapy was administered to the patient.
• The treatment led to significant improvement in all clinical symptoms associated with SLE and PLE.
• Laboratorial findings and intestinal histological alterations showed positive responses to corticosteroid intervention.

Implications:

• Corticosteroids represent a viable therapeutic option for managing protein-losing enteropathy in SLE patients with intestinal lymphangiectasia.
• This case highlights the importance of considering gastrointestinal manifestations in SLE management.
• Further research may explore the long-term efficacy and optimal dosing of corticosteroids in similar cases.